
Betty Wang, MD, BS, University of Alberta, and colleagues reported significant inter-site variation—independent of differences in tumor factors—in recurrence of non-muscle-invasive bladder cancer (NMIBC) after transurethral resection of bladder tumor (TRUBT) in the RESECT study.
Their study won the best poster for the Bladder Cancer: Non-Invasive session at the American Urological Association 2023 meeting.
RESECT is an international, multi-center, observational study that sought to determine if audit and feedback can improve the quality of TURBT surgery and reduce early recurrence rates in NMIBC. A mixed effects logistic regression model with tumor size, number, grade, and stage as fixed effects, as well as site as a random effect, was fitted. Cases with first, presumed NMIBC undergoing TURBT were included, while cases in which first check follow-up had not been completed were excluded.